Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 791 shares (grant or award)
  2. 4 Grant or award Director acquired 791 shares (grant or award)
  3. 4 Gift President & CEO gave 25,000 shares (gift)
  4. 4 Grant or award Director acquired 16,745 shares (grant or award)
  5. 4 Grant or award Director acquired 16,745 shares (grant or award)
  6. 4 Grant or award Director acquired 16,745 shares (grant or award)
  7. 4 Grant or award Director acquired 16,745 shares (grant or award)
  8. 4 Open-market sale Director sold 4,000 shares at $7.98 ($31,920)
  9. 4 Grant or award Director acquired 16,745 shares (grant or award)
  10. 4 Open-market sale Director sold 12,866 shares at $8.04 ($103,443)
  11. 4 Grant or award Director acquired 16,745 shares (grant or award)
  12. 4 Grant or award Director acquired 16,745 shares (grant or award)
  13. 4 Grant or award Director acquired 16,745 shares (grant or award)
  14. 4 Grant or award Director acquired 680 shares (grant or award)
  15. 4 Grant or award Director acquired 1,360 shares (grant or award)
  16. 4 Grant or award Director acquired 680 shares (grant or award)
  17. 4 Planned sale Chief R&D Officer sold 7,000 shares at $8.29 ($58,030)
  18. 4 Exercise or conversion President & CEO acquired 31,055 shares (option exercise)
  19. 4 Grant or award Director acquired 635 shares (grant or award)
  20. 4 Grant or award Director acquired 2,259 shares (grant or award)

Page 7 of 49 · 965 filings